Use of increasing doses of a degradable Deslorelin implant to enhance uterine involution in postpartum lactating dairy cows

[Influence of an eCG administration on puerperal involution and fertility in Simmentaler cows]

SUBJECT AND AIM

In the literature, various methods aiming for a promotion of uterine involution and ovarian function in post-partum dairy cattle have been described. Recently, successful use of equine choriongonadotropin (eCG) in this context has been repeatedly reported, while other studies have failed to demonstrate positive effects of eCG administration on puerperal involution in cows. Due to the contradictory results described in the literature, the aim of this field study was to verify whether the administration of eCG on day 10 post-partum exerts a positive effect on uterine involution, ovarian activity and fertility indices in Simmental cows.

MATERIAL AND METHODS

In nine dairy farms, 205 Simmental cows were divided by lot into three groups: Group 1 animals received 500 I.U. eCG, group 2 received 50 µg gonadorelin, and group 3 animals received 250 mg butafosfan and 125 µg cyanocobalamin (control group). Treatment was administered on day 10 post-partum in each case. The animals were examined clinically and ultrasonographically on the 10th, 25th and 42nd day post-partum and the time to insemination and pregnancy were recorded. Group comparison with respect to the recorded parameters was initially performed without considering confounding factors by analysis of variance. In the second step, potential influencing variables (lactation, milk yield, change in backfat thickness, retentio secundarium and serverity of the obstetric intervention) were taken into account, as well as the combination of the random factors "farm" and "individual animal within the farm".

RESULTS

The administration of eCG exhibited no significant effect on uterine involution, however, the cervical involution was influenced significantly. In the group of cows with eCG treatment, ovarian cysts were detected significantly more frequently on day 25 post-partum (p=0.04). This difference did not persist on the 42nd day post-partum. Neither voluntary waiting period nor the days open were significantly shortened by eCG administration. Lactation number showed a significant effect on uterine involution. Heifers exhibited more rapid involution by day 42 post-partum than cows.

CONCLUSION

Administration of eCG in Simmentaler cows at day 10 post-partum showed no positive effect.

CLINICAL RELEVANCE

The use of eCG in early puerperium to promote fertility in the cow should be avoided.

Effect of equine chorionic gonadotropin administration on day 8 post-partum on ovarian follicular development, uterine health and uterine involution in lactating dairy cows

The objective was to evaluate the effect of equine chorionic gonadotropin (eCG) injection on day 8 postpartum on ovarian cyclicity, uterine health and uterine involution in lactating dairy cows. Lactating dairy cows [n = 34, (21 primiparous and 13 multiparous)] were enrolled in the study. Animals were stratified by calving date, parity and BCS, and randomly assigned to either control (CON n = 18) or eCG treatments (n = 16). On day 8 ± 0.9 post-partum (pp), eCG treatment cows received a 2 ml i.m. injection (500 IU) of eCG and control treatment cows received a 2 ml i.m. injection of 0.9% sodium chloride. Ovaries were examined by transrectal ultrasound every second day from day 10 pp until ovulation or regression of the first follicle wave, and the diameter of the dominant follicle was recorded at each exam. Ultrasound exams were conducted on days 21, 28, 35 and 42 pp to measure the diameter of the cervix and the uterine horns. Vaginal discharge score (VDS) was recorded on a 1 to 5 scale on days 14, 21, 28, 35 and 42 pp. Endometrial cytology samples were collected on day 42 pp, and the percentage of polymorphonuclear neutrophils (PMN) determined. Milk samples were collected three times per week from day 14 pp until day 60 pp for P4 determination. Ovarian follicular development variables, ovarian function variables analysed and incidence of subclinical endometritis were not affected by treatment. There was a treatment by parity interaction for pp interval to commencement of luteal activity (P = 0.04) and number of luteal phases (P = 0.05), whereby eCG treatment caused an earlier pp commencement of luteal activity and a greater number of luteal phases in multiparous cows, but not in primiparous cows. A significant effect of treatment on uterine involution was observed (previously gravid horn: P = 0.03; previously non-gravid horn: P = 0.01) and uterine health status (P = 0.03), whereby eCG cows had smaller mean horn uterine diameter and lesser VDS than CON cows. In summary, parenteral administration of 500 IU eCG on day 8 post-partum did not affect resumption of ovarian cyclicity in all cows but did enhance uterine involution and VDS. In multiparous cows, eCG advanced commencement of luteal activity and increased the number of luteal phases.

Early postpartum administration of equine chorionic gonadotropin to dairy cows calved during the hot season: Effects on fertility after first artificial insemination

Heat stress reduces fertility of high-producing dairy cows, and early administration of equine chorionic gonadotropin (eCG) may improve it. Here, 401 heat-stressed, high-producing dairy cows on a single commercial farm were given eCG (500 UI, n = 214) or saline (n = 187) on days 11-17 after calving, and the effects on fertility after the first artificial insemination (AI) were assessed. On post-partum day 96.34 ± 9.88, all cows were inseminated after a "double short Cosynch" synchronization protocol. Ovarian activity and uterine status were checked by ultrasound on the day of eCG administration and every 7 days thereafter for a total of 3 weeks; checks were also performed during synchronization, and 7 days after AI. On post-partum day 30, cytobrush uterine cytology was performed to check for subclinical endometritis. Pregnancy status was checked on days 30 and 60 after AI. The eCG and control groups did not differ significantly in terms of average lactations per cow (2.33 ± 1.34), days in milk at first AI (96.33 ± 9.88), average milk yield at AI (41.38 ± 7.74 L), or the particular inseminator or bull used for AI. The eCG and control groups showed increasing ovarian activity with time, with approximately 75% of cows in both groups showing a corpus luteum at the beginning of the synchronization protocol. On post-partum day 30, 17.4% of eCG cows and 22.9% of control cows showed subclinical endometritis. Cows treated with eCG showed a tendency toward lower hyperecogenic intraluminal content (16.8 vs. 21.4%, P = 0.15), but ovarian activity during the synchronization protocol was similar between eCG and control groups, with 91% of animals in both groups showing luteolysis after prostaglandin application and 88% showing ovulation after the last administration of gonadotropin-releasing hormone. Fertility was similar between the two groups at both time points after AI (30 days, 34.9 vs. 31.8%; 60 days, 30.6 vs. 28.5%; P > 0.2). These results suggest that early postpartum eCG administration does not improve fertility of heat-stressed dairy cows as long as 60 days after AI. Other strategies may be more effective at mitigating the ability of post-partum heat stress to reduce fertility of high-producing dairy cows.

Evaluation of the efficacy and safety of single administration of 4.7-mg deslorelin acetate implants on egg production and plasma sex hormones in Japanese quail (Coturnix coturnix japonica)

OBJECTIVE

To evaluate the effects of 4.7-mg deslorelin acetate implants on egg production and plasma concentrations of 17β-estradiol and androstenedione in Japanese quail (Coturnix coturnix japonica) over 180 days and assess safety of the implants in quail via gross and histologic examination.

ANIMALS

20 female Japanese quail.

PROCEDURES

Following a 7-day period of consistent egg laying, quail were anesthetized and received a 4.7-mg deslorelin implant (treatment group; n = 10) or identical placebo implant (control group; 10) SC between the scapulae. Egg production was monitored daily. Plasma concentrations of 17β-estradiol and androstenedione were measured on days 0 (immediately prior to implant injection), 14, 29, 62, 90, 120, 150, and 180 via radioimmunoassay. Birds were weighed periodically and euthanized at day 180 for complete necropsy.

RESULTS

Egg production was significantly decreased in the treatment group, compared with the control group, from 2 to 12 weeks after implant injection. Egg production ceased in 6 of 10 quail in the treatment group (mean duration of cessation, 70 days). Plasma androstenedione and 17β　-estradiol concentrations were significantly lower on day 29 in the treatment group than in the control group. On day 180, 17β　-estradiol concentration was lower in control than in treated birds.No clinically relevant lesions were detected in either group at necropsy [corrected].

CONCLUSIONS AND CLINICAL RELEVANCE

4.7-mg deslorelin acetate implants reversibly decreased egg laying for approximately 70 days in most of the Japanese quail evaluated. Further studies evaluating implants containing different concentrations of the drug are needed in quail and other avian species.

Effect of intrauterine dextrose or antibiotic therapy on reproductive performance of lactating dairy cows diagnosed with clinical endometritis

The objectives of this study were to assess the responses to treatments (clinical cure and cow survival 14 d posttherapy) of cows with clinical endometritis (CE) that received intrauterine infusion of a hypertonic solution of 50% dextrose (DEX) or subcutaneous ceftiofur crystalline free acid (CCFA) and subsequent pregnancy per artificial insemination (P/AI) in cows with CE compared with cows without CE. Cows (n=760) from 2 dairy herds were screened for CE using vaginoscopy and measurement of cervix diameters [exam 1; 26±3 d in milk (DIM)]. Cows with vaginal discharge scores of 2 or 3 (scale 0-3) were stratified by parity and randomly allocated into 1 of 3 treatment groups: (1) intrauterine infusion (∼200 mL) of 50% DEX solution (n=79); (2) 6.6 mg/kg single-dose of subcutaneous administration of CCFA (n=75); or (3) untreated control animals (CON, n=83). Fourteen days posttherapy (at 40±3 DIM), cows with CE were re-examined (exam 2; 40±3 DIM) to assess the response to treatments. All cows were presynchronized with 2 injections of PGF(2α) given 14 d apart (starting at 26±3 DIM) followed by Ovsynch (OV; GnRH-7 d-PGF-56 h-GnRH 16 h-timed-AI) 12 to 14 d later. Cows displaying signs of standing estrus any time during the protocol were inseminated, whereas the remaining cows were subjected to timed AI 16 h after the second GnRH of OV. Pregnancy diagnosis was performed via transrectal ultrasonography at 39±3d post-AI followed by pregnancy reconfirmation 30 d after the first pregnancy diagnosis. Uterine swabs revealed that Arcanobacterium pyogenes and Escherichia coli were the most predominant bacteria isolated at the time of treatments. Mortality within 14 d posttherapy was not different among treatment groups. Cows with CE had greater cervical diameter at exam 1 and decreased P/AI compared with cows without CE. Treatment with CCFA or DEX increased the proportion of cows with clear vaginal discharge (score 0; clinical cure) 14 d posttherapy compared with CON cows. Pregnancy per AI from DEX (29.8±4%) cows tended to differ from that of CON (21.1±4%) or CCFA cows (19.7±4%), but it resulted in similar P/AI as those cows without CE (39.1±2%). The use of intrauterine DEX alone or as an adjunct of antibiotic therapy for the treatment of CE needs further investigation.